This move is archived. Current quotes and coverage live on the stock page.
Get APTX alerts:
Apotex Health Corp's stock surged by over 5% in the last trading session, marking a significant milestone in its market journey.
In a noteworthy performance on the Toronto Stock Exchange, Apotex Health Corp (APTX.TO) saw its stock price increase by 5.26%, closing at CA$36.44. This upward momentum reflects growing investor confidence in the company's recent strategic moves and market positioning.
Advertisement
Apotex Health Corp
APTX.TO
APTX.TO
Apotex Health Corp
WealthAwesomeMarket cap
$7.55B
52W high
$40.18
52W low
$26.05
1W change
-3.05%
Analyst Price Targets
Based on analyst covering APTX
Wall Street analysts forecast APTX stock price to rise 27.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$41.34
+27.7% Upside
Current Price
C$32.37
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APTX's historical volatility
30-Day Vol
42.6%
Annualized
90-Day Vol
48.9%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$38.70
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$34.36 | C$29.66 – C$39.80 |
| 60 trading days | C$36.46 | C$29.62 – C$44.89 |
| 90 trading days | C$38.70 | C$30.00 – C$49.92 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: For Canadian investors, Apotex Health Corp's recent gains highlight the potential of biotech firms in the current market, especially those making strides in product approvals and strategic partnerships.
Apotex Health Corp's stock rises 5.26% in one day
With a market cap of CA$7.87 billion, Apotex is now a significant player in the Canadian biotech landscape, reflecting its growing influence and investor interest.
Bull case
The recent approval of SEVMIA™, a generic semaglutide for chronic weight management, puts Apotex Health Corp in a strong position within the expanding health sector. This product could tap into a lucrative market, driving revenue growth and boosting investor sentiment.
Bear case
Despite today's gains, the biotech sector can be unpredictable. Any setbacks in product launches or regulatory hurdles could affect Apotex's stock performance. Investors should stay cautious and keep an eye on upcoming developments closely.
Market Performance Overview
Advertisement
In the latest trading session, Apotex Health Corp's stock closed at CA$36.44, reflecting a 5.26% increase. This surge is indicative of a positive market reception following the company's strategic initiatives and recent product approvals, particularly in the competitive biotech sector.
Strategic Developments Fueling Growth
Apotex's recent approval for SEVMIA™ positions the company to capitalize on the growing demand for chronic weight management solutions. This approval not only enhances its product portfolio but also strengthens its market presence, attracting investor interest and boosting stock performance.
Investor Sentiment and Future Outlook
The current upward trend in Apotex's stock reflects a broader optimism in the biotech sector. However, investors should remain vigilant regarding potential market fluctuations and the company's ability to navigate regulatory challenges as it continues to expand its offerings.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
